The DOI matches its Crossref record; 312 of the 312 references it cites were found in a registry or an index.
Targeting Early Atherosclerosis: A Focus on Oxidative Stress and Inflammation
Open accessAbstract
Atherosclerosis is a chronic vascular inflammatory disease associated to oxidative stress and endothelial dysfunction. Oxidation of low-density lipoprotein (LDL) cholesterol is one of the key factors for the development of atherosclerosis. Nonoxidized LDL have a low affinity for macrophages, so they are not themselves a risk factor. However, lowering LDL levels is a common clinical practice to reduce oxidation and the risk of major events in patients with cardiovascular diseases (CVD). Atherosclerosis starts with dysfunctional changes in the endothelium induced by disturbed shear stress which can lead to endothelial and platelet activation, adhesion of monocytes on the activated endothelium, and differentiation into proinflammatory macrophages, which increase the uptake of oxidized LDL (oxLDL) and turn into foam cells, exacerbating the inflammatory signalling. The atherosclerotic process is accelerated by a myriad of factors, such as the release of inflammatory chemokines and cytokines, the generation of reactive oxygen species (ROS), growth factors, and the proliferation of vascular smooth muscle cells. Inflammation and immunity are key factors for the development and complications of atherosclerosis, and therefore, the whole atherosclerotic process is a target for diagnosis and treatment. In this review, we focus on early stages of the disease and we address both biomarkers and therapeutic approaches currently available and under research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–312 of 312
Hydrogen sulfide derived from periadventitial adipose tissue is a vasodilator
Fang, L., Zhao, J., Chen, Y., Ma, T., Xu, G., Tang, C., Liu, X., & Geng, B. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e328330a900 · Cited by 150
Rashid, S., Tavori, H., Brown, P. E., Linton, M. F., He, J., Giunzioni, I., & Fazio, S. (2014) · Circulation · doi:10.1161/circulationaha.113.006720 · Cited by 148
Catapano, A. L., Pirillo, A., & Norata, G. D. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13805 · Cited by 148
The Multifaceted Clinical Readouts of Platelet Inhibition by Low-Dose Aspirin
Patrono, C. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.05.012 · Cited by 145
Molecular and mechanical bases of focal lipid accumulation in arterial wall
Chien, S. (2003) · Progress in Biophysics and Molecular Biology · doi:10.1016/s0079-6107(03)00053-1 · Cited by 144
Trichostatin A Exacerbates Atherosclerosis in Low Density Lipoprotein Receptor–Deficient Mice
Choi, J., Nam, K., Kim, J.-Y., Baek, M. W., Park, J.-E., Park, H., Kwon, H. J., Kwon, O., Kim, D.-Y., & Oh, G. T. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000184758.07257.88 · Cited by 143
Endothelial Cells: From Dysfunction Mechanism to Pharmacological Effect in Cardiovascular Disease
Haybar, H., Shahrabi, S., Rezaeeyan, H., Shirzad, R., & Saki, N. (2018) · Cardiovascular Toxicology · doi:10.1007/s12012-018-9493-8 · Cited by 143
Dual Roles of Adiponectin / Acrp30 In Vivo as an Anti-Diabetic and Anti- Atherogenic Adipokine
Yamauchi, T., Hara, K., Kubota, N., Terauchi, Y., Tobe, K., Froguel, P., Nagai, R., & Kadowaki, T. (2003) · Current Drug Targets - Immune Endocrine & Metabolic Disorders · doi:10.2174/1568008033340090 · Cited by 142
Heitzer, T. A., Rudolph, V., Schwedhelm, E., Karstens, M., Sydow, K., Ortak, M., Tschentscher, P., Meinertz, T., Böger, R. H., & Baldus, S. E. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000225288.74170.dc · Cited by 141
Adiponectin prevents atherosclerosis by increasing cholesterol efflux from macrophages
Tsubakio‐Yamamoto, K., Matsuura, F., Koseki, M., Oku, H., Sandoval, J. C., Inagaki, M., Nakatani, K., Nakaoka, H., Kawase, R., Yuasa‐Kawase, M., et al. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.08.009 · Cited by 139
Kumar, A., Kumar, S., Vikram, A., Hoffman, T. A., Naqvi, A., Lewarchik, C. M., Kim, Y., & Irani, K. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.301765 · Cited by 137
Nox4-derived reactive oxygen species mediate cardiomyocyte injury in early type 1 diabetes
Maalouf, R., Eid, A. A., Gorin, Y. C., Block, K. L., Escobar, G. P., Bailey, S. R., & Abboud, H. E. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00331.2011 · Cited by 136
Cooke, J. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0430082100 · Cited by 135
Endothelial progenitor cells in atherosclerosis
Du, F. (2012) · Frontiers in bioscience · doi:10.2741/4055 · Cited by 135
Massaro, M., Zampolli, A., Scoditti, E., Carluccio, M. A., Storelli, C., Distante, A., & Caterina, R. D. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp375 · Cited by 134
Non-proinflammatory and responsive nanoplatforms for targeted treatment of atherosclerosis
Dou, Y., Chen, Y., Zhang, X., Xu, X., Chen, Y., Guo, J., Zhang, D., Wang, R., Li, X., & Zhang, J. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.07.035 · Cited by 134
Langbein, H., Brunssen, C., Hofmann, A., Cimalla, P., Brux, M., Bornstein, S. R., Deussen, A., Koch, E., & Morawietz, H. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv564 · Cited by 133
Interleukin-1 Regulates Multiple Atherogenic Mechanisms in Response to Fat Feeding
Chamberlain, J., Francis, S., Brookes, Z. L. S., Shaw, G., Graham, D., Alp, N. J., Dower, S., & Crossman, D. C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005073 · Cited by 132
Interleukin 18 and coronary heart disease: Prospective study and systematic review
Jefferis, B. J. M. H., Papacosta, O., Owen, C. G., Wannamethee, S. G., Humphries, S. E., Woodward, M., LENNON, L. T., Thomson, A. G., Welsh, P. I., Rumley, A., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.03.015 · Cited by 128
Tuñón, J., Badimón, L., Bochaton‐Piallat, M., Cariou, B., Daemen, M. J. A. P., Egido, J., Evans, P. C., Hoefer, I. E., Ketelhuth, D. F. J., Lutgens, E., et al. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy293 · Cited by 127
Bos, D., Leening, M. J. G., Kavousi, M., Albert Hofman, D., Franco, O. H., van der Lugt, A., Vernooij, M. W., & Ikram, M. A. (2015) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.115.003843 · Cited by 122
Differential metabolic effects of pravastatin and simvastatin in hypercholesterolemic patients
Koh, K. K., Quon, M. J., Han, S. H., Lee, Y., Kim, S. J., Park, J. B., & Shin, E. K. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.09.021 · Cited by 119
Multiple Inflammatory Biomarkers in Relation to Cardiovascular Events and Mortality in the Community
Schnabel, R. B., Yin, X., Larson, M. G., Yamamoto, J. F., Fontes, J. D., Kathiresan, S., Rong, J., Levy, D. A., Keaney, J. F., Wang, T. J., et al. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.301174 · Cited by 117
Chen, X.-P., Xun, K.-L., Wu, Q., Zhang, T.-T., Shi, J.-S., & Du, G.-H. (2007) · Vascular Pharmacology · doi:10.1016/j.vph.2007.01.004 · Cited by 115
Wang, Z., Liu, B., Zhu, J., Wang, D., & Wang, Y. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.02.008 · Cited by 114
Statins Induce the Accumulation of Regulatory T Cells in Atherosclerotic Plaque
Meng, X., Zhang, K., Li, J., Dong, M., Yang, J., An, G., Qin, W., Gao, F., Zhang, C., & Zhang, Y. (2012) · Molecular Medicine · doi:10.2119/molmed.2011.00471 · Cited by 112
Wu, N., Bredin, S. S. D., Guan, Y., Dickinson, K., Kim, D. D., Chua, Z., Kaufman, K., & Warburton, D. E. R. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8020253 · Cited by 110
Leukotriene receptors in atherosclerosis
Bäck, M., & Hansson, G. K. (2006) · Annals of Medicine · doi:10.1080/07853890600982737 · Cited by 109
Zhang, S., Zou, J., Li, P., Zheng, X., & Feng, D. (2017) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b04260 · Cited by 109
Zhang, C., & Melendez, A. J. (2007) · Cell Adhesion & Migration · doi:10.4161/cam.1.4.5321 · Cited by 107
Shear Stress Regulates Occludin and VEGF Expression in Porcine Arterial Endothelial Cells
Conklin, B. S., Zhong, D., Zhao, W., Lin, P. H., & Chen, C. (2002) · Journal of Surgical Research · doi:10.1006/jsre.2001.6295 · Cited by 106
Corti, R., Osende, J. I., Fallon, J. T., Fuster, V., Mizsei, G., Jneid, H. M., Wright, S. D., Chaplin, W. F., & Badimón, J. J. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.08.048 · Cited by 100
Physical inactivity, insulin resistance, and the oxidative-inflammatory loop
Gratas-Delamarche, A., Derbré, F., Vincent, S., & Cillard, J. (2014) · Free Radical Research · doi:10.3109/10715762.2013.847528 · Cited by 99
Smoking and Endothelial Dysfunction
Golbidi, S., Edvinsson, L. I., & Laher, I. (2018) · Current Vascular Pharmacology · doi:10.2174/1573403x14666180913120015 · Cited by 98
Lipoproteínas, plaquetas y aterotrombosis
Badimón, L., Vilahur, G., & Padró, T. (2009) · Revista Española de Cardiología · doi:10.1016/s0300-8932(09)72385-1 · Cited by 97
Thioredoxin in the cardiovascular system
WORLD, C., Yamawaki, H., & Berk, B. C. (2006) · Journal of Molecular Medicine · doi:10.1007/s00109-006-0109-6 · Cited by 97
Physical Activity and Adiposity-related Inflammation: The MESA
Vella, C. A., Allison, M., Cushman, M., Jenny, N. S., Miles, M. P., Larsen, B. A., Gilchrist, S. C., Michos, E. D., & Blaha, M. J. (2016) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000001179 · Cited by 96
Valproate Attenuates Accelerated Atherosclerosis in Hyperglycemic ApoE-Deficient Mice
Bowes, A. J., Khan, M. I., Shi, Y., Robertson, L. A., & Werstuck, G. H. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080385 · Cited by 95
Celastrol-loaded PEG- b -PPS nanocarriers as an anti-inflammatory treatment for atherosclerosis
Allen, S. D., Liu, Y.-G., Kim, T., Bobbala, S., Yi, S., Zhang, X., Choi, J., & Scott, E. A. (2019) · Biomaterials Science · doi:10.1039/c8bm01224e · Cited by 95
Lin, X., Liu, M., Hu, H.-J., Feng, H., Fan, X., Zou, W.-W., Pan, Y., Hu, X., & Wang, Z. (2015) · DNA and Cell Biology · doi:10.1089/dna.2015.2866 · Cited by 92
Cross-Talk Between PCSK9 and Damaged mtDNA in Vascular Smooth Muscle Cells: Role in Apoptosis
Ding, Z., Liu, S., Wang, X., Mathur, P., Dai, Y., Theus, S. A., Deng, X., Fan, Y., & Mehta, J. L. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6631 · Cited by 92
Qi, G., Jia, L., Li, Y., Bian, Y., Cheng, J., Li, H., Xiao, C., & Du, J. (2011) · Cardiovascular Toxicology · doi:10.1007/s12012-011-9109-z · Cited by 89
Shrikhande, G., Scali, S. T., da Silva, C. G., Damrauer, S. M., Csizmadia, E., Putheti, P., Matthey, M., Arjoon, R., Patel, R., Siracuse, J. J., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014240 · Cited by 89
Experimental and clinical pharmacology: PCSK9 inhibitors - mechanisms of action
Page, M. M., & Watts, G. F. (2016) · Australian Prescriber · doi:10.18773/austprescr.2016.060 · Cited by 89
O’Keeffe, L. M., Simpkin, A. J., Tilling, K. M., Anderson, E. L., Hughes, A. D., Lawlor, D. A., Fraser, A., & Howe, L. D. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.09.030 · Cited by 87
Endothelial NADPH oxidase 4 protects ApoE-/- mice from atherosclerotic lesions
Craige, S. M., Kant, S., Reif, M., Chen, K., Pei, Y., Angoff, R., Sugamura, K., Fitzgibbons, T., & Keaney, J. F. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.07.004 · Cited by 85
Abbate, A., Tassell, B. W. V., & Biondi‐Zoccai, G. (2012) · BioDrugs · doi:10.1007/bf03261881 · Cited by 84
Stem cell-based peripheral vascular regeneration
Fujita, Y., & Kawamoto, A. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.09.001 · Cited by 80
El‐Remessy, A. B., Tawfik, H. E., Matragoon, S., Pillai, B. A., Caldwell, R. B., & Caldwell, R. W. (2010) · Experimental Diabetes Research · doi:10.1155/2010/247861 · Cited by 79
Takagi, Y., Gon, Y., Todaka, T., Nozaki, K., Nishiyama, A., Sono, H., Hashimoto, N., Kikuchi, H., & Yodoi, J. (1998) · PubMed · Cited by 78
Function and Therapeutic Potential of Mesenchymal Stem Cells in Atherosclerosis
Li, F., Guo, X., & Chen, S. (2017) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2017.00032 · Cited by 76
Associations between sedentary behaviours and dietary intakes among adolescents
Fletcher, E. A., McNaughton, S. A., Crawford, D. A., Cleland, V. J., Gatta, J. D., Hatt, J., Dollman, J., & Timperio, A. F. (2018) · Public Health Nutrition · doi:10.1017/s136898001700372x · Cited by 76
Innate and adaptive immunity in atherosclerosis
Miteva, K., Madonna, R., Caterina, R. D., & Linthout, S. V. (2018) · Vascular Pharmacology · doi:10.1016/j.vph.2018.04.006 · Cited by 76
PCSK9: A novel inflammation modulator in atherosclerosis?
Tang, Z., Li, T., Peng, J., Zheng, J., Li, T., Liu, L., Jiang, Z., & Zheng, X. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27254 · Cited by 76
Markers of Atherosclerosis: Part 1 – Serological Markers
Tibaut, M., Čaprnda, M., Kubatka, P., Sinkovič, A., Valentová, V., Filipová, S., Gazdíková, K., Gašpar, Ľ., Mozos, I. M., Egom, E. E. A., et al. (2018) · Heart Lung and Circulation · doi:10.1016/j.hlc.2018.06.1057 · Cited by 74
Mesenchymal Stem Cells Reduce Murine Atherosclerosis Development
Frodermann, V., van Duijn, J., van Pel, M., van Santbrink, P. J., Bot, I., Kuiper, J., & de Jager, S. C. A. (2015) · Scientific Reports · doi:10.1038/srep15559 · Cited by 73
Cheng, F., Torzewski, M., Degreif, A., Rossmann, H., Canisius, A., & Lackner, K. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072063 · Cited by 73
Toll‐Like Receptor 9 Plays a Pivotal Role in Angiotensin II–Induced Atherosclerosis
Fukuda, D., Nishimoto, S., Aini, K., Tanaka, A., Nishiguchi, T., Kim‐Kaneyama, J., Lei, X., Masuda, K., Naruto, T., Tanaka, K., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.010860 · Cited by 73
Zeng, Q., Han, Y. H., Bao, Y., Li, W., Li, X., Shen, X., Wang, X., Yao, F., O’Rourke, S. T., & Sun, C. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00067.2010 · Cited by 72
Gonon, A. T., Bulhak, A., Labruto, F., Sjöquist, P.-O. B., & Pernow, J. (2006) · Basic Research in Cardiology · doi:10.1007/s00395-006-0613-4 · Cited by 71
Physiological and pathological views of peroxiredoxin 4
Fujii, J., Ikeda, Y., Kurahashi, T., & Homma, T. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.01.025 · Cited by 69
Kelley, W. J., Safari, H., Lopez‐Cazares, G., & Eniola‐Adefeso, O. (2016) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1414 · Cited by 66
Kowalski, P. S., Lintermans, L. L., Morselt, H. W. M., Leus, N. G. J., Ruiters, M. H. J., Molema, G., & Kamps, J. A. A. M. (2013) · Molecular Pharmaceutics · doi:10.1021/mp4001124 · Cited by 65
Understanding PCSK9 and anti-PCSK9 therapies
McKenney, J. M. (2015) · Journal of clinical lipidology · doi:10.1016/j.jacl.2015.01.001 · Cited by 64
Endothelial Dysfunction in Morbid Obesity
Mauricio, M. D., Aldasoro, M., Ortega, J., & Vila, J. M. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319320007 · Cited by 64
Self-citationKarnewar, S., Vasamsetti, S. B., Gopoju, R., Kanugula, A. K., Ganji, S. K., Prabhakar, S., Rangaraj, N., Tupperwar, N., Kumar, J. M., & Kotamraju, S. (2016) · Scientific Reports · doi:10.1038/srep24108 · Cited by 62
Kajikawa, M., Higashi, Y., Tomiyama, H., Maruhashi, T., Kurisu, S., Kihara, Y., Mutoh, A., & Ueda, S. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.01.054 · Cited by 62
Mesenchymal Stem Cells Ameliorate Atherosclerotic Lesions via Restoring Endothelial Function
Lin, Y., Yet, S., Hsu, Y., Wang, G., & Hung, S. (2014) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0091 · Cited by 61
Lee, W., Allison, M., Kim, D., Song, C.-H., & Barrett-Connor, E. L. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.07.070 · Cited by 61
Kirsch, J., Schneider, H., Pagel, J.-I., Rehberg, M., Singer, M. S., Hellfritsch, J., Chillo, O., Schubert, K., Qiu, J., Pogoda, K., et al. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.307843 · Cited by 61
Targeting vasa vasorum dysfunction to prevent atherosclerosis
Boyle, E. C., Sedding, D. G., & Haverich, A. (2017) · Vascular Pharmacology · doi:10.1016/j.vph.2017.08.003 · Cited by 60
Potential epigenetic therapeutics for atherosclerosis treatment
Nicorescu, I., Dallinga‐Thie, G. M., de Winther, M. P. J., Stroes, E. S. G., & Bahjat, M. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.10.006 · Cited by 57
Immunohistochemical analysis of paraoxonases-1 and 3 in human atheromatous plaques
Marsillach, J., Camps, J., Beltrán‐Debón, R., Rull, A., Aragonès, G., Maestre‐Martínez, C., Sabench, F., Hernández, M., Castillo, D. D., Joven, J., et al. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02411.x · Cited by 55
Xu, L., Wang, S., Li, B., Sun, A., Zou, Y., & Ge, J. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12463 · Cited by 55
Xanthine Oxidase Induces Foam Cell Formation through LOX-1 and NLRP3 Activation
Dai, Y., Cao, Y., Zhang, Z., Vallurupalli, S., & Mehta, J. L. (2017) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-016-6706-x · Cited by 53
Markers of Atherosclerosis: Part 2 – Genetic and Imaging Markers
Tibaut, M., Čaprnda, M., Kubatka, P., Sinkovič, A., Valentová, V., Filipová, S., Gazdíková, K., Gašpar, Ľ., Mozos, I. M., Egom, E. E. A., et al. (2018) · Heart Lung and Circulation · doi:10.1016/j.hlc.2018.09.006 · Cited by 53
Altabas, V., Altabas, K., & Kirigin, L. S. (2016) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.02.009 · Cited by 50
Zhao, Y., Evans, M. A., Allison, M., Bertoni, A. G., Budoff, M. J., Criqui, M. H., Malik, S., Ouyang, P., Polak, J. F., & Wong, N. D. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.12.005 · Cited by 48
Reversal of coronary atherosclerosis: Role of life style and medical management
Parsons, C. E., Agasthi, P., Mookadam, F., & Arsanjani, R. (2018) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2018.05.002 · Cited by 46
The Role of Colchicine in Acute Coronary Syndromes
Vaidya, K., Martínez, G., & Patel, S. (2018) · Clinical Therapeutics · doi:10.1016/j.clinthera.2018.07.023 · Cited by 43
Turgeon, R. D., Tsuyuki, R. T., Gyenes, G. T., & Pearson, G. J. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2018.04.002 · Cited by 43
The Association of Circulating MiR-29b and Interleukin-6 with Subclinical Atherosclerosis
Huang, Y., Li, J., Chen, J.-Y., Zhou, Y.-L., Cai, A.-P., Huang, C. Y., & Feng, Y. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000485649 · Cited by 42
Nakagomi, A., Shibui, T., Kohashi, K., Kosugi, M., Kusama, Y., Atarashi, H., & Shimizu, W. (2015) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.29520 · Cited by 41
Clarity on the Isoform-Specific Roles of NADPH Oxidases and NADPH Oxidase-4 in Atherosclerosis
Fulton, D. J., & Barman, S. A. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.307096 · Cited by 41
Recent advances on CD4 + T cells in atherosclerosis and its implications for therapy
Grönberg, C., Nilsson, J. Å., & Wigren, M. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.04.029 · Cited by 38
Burchardt, P., Żurawski, J., Żuchowski, B., Kubacki, T., Murawa, D., Wiktorowicz, K., & Wysocki, H. (2013) · Archives of Medical Science · doi:10.5114/aoms.2013.33176 · Cited by 37
Chen, B., Wei, J.-G., Wang, W., Cui, G., Zhao, Y., Zhu, X., Zhu, M., Guo, W., & Yu, J. M. (2009) · Archives of Medical Research · doi:10.1016/j.arcmed.2009.03.007 · Cited by 37
Leverence, J. T., Medhora, M. M., Konduri, G. G., & Sampath, V. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.09.026 · Cited by 37
Essential Roles of Toll-Like Receptors in Atherosclerosis
Lin, J., Kakkar, V. V., & Lu, X. (2016) · Current Medicinal Chemistry · doi:10.2174/0929867323666151207111408 · Cited by 37
Circulating PCSK9 levels in acute coronary syndrome: Results from the PC-SCA-9 prospective study
Cariou, B., Guérin, P., May, C. L., Letocart, V., Arnaud, L., Guyomarch, B., Pichelin, M., & Probst, V. (2017) · Diabetes & Metabolism · doi:10.1016/j.diabet.2017.07.009 · Cited by 37
Basic Nuclear Processes Affected by Histone Acetyltransferases and Histone Deacetylase Inhibitors
Legartová, S., Stixová, L., Strnad, H., Kozubek, S., Martinet, N., Dekker, F. J., Franek, M., & Bártová, E. (2013) · Epigenomics · doi:10.2217/epi.13.38 · Cited by 36
Georgescu, A., Alexandru, N., Andrei, E., Dragan, E., Cochior, D., & Dias, S. (2016) · Biology of the Cell · doi:10.1111/boc.201500104 · Cited by 36
Chen, Y., Zheng, Y., Liu, L., Lin, C., Liao, C., Xin, L., Zhong, S., Cheng, Q., & Zhang, L. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000480006 · Cited by 36
Effect of S-adenosylmethionine on neointimal formation after balloon injury in obese diabetic rats
Lim, S. K., Moon, M. K., Shin, H., Kim, T. H., Cho, B. J., Kim, M. G., Park, H. S., Choi, S. H., Ko, S.-H., Chung, M. H., et al. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr009 · Cited by 35
Influence of exercise training mode on arterial diameter: A systematic review and meta-analysis
Black, J. M., Stöhr, E. J., Shave, R., & Esformes, J. I. (2014) · Journal of science and medicine in sport · doi:10.1016/j.jsams.2014.12.007 · Cited by 33
Vascular Inflammation: A Novel Access Route for Nanomedicine
Molinaro, R., Boada, C., del Rosal, G. M., Hartman, K. A., Corbo, C., Andrews, E. D., Furman, N. E. T., Cooke, J. P., & Tasciotti, E. (2016) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcj-12-3-169 · Cited by 33
Cai, Y., Xie, K., Fan, Z., & Liu, S. (2018) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-018-9828-7 · Cited by 33
Lin, H., Daimon, M., Wang, C., Ho, Y., Uang, Y., Chiang, S.-J., & Wang, L. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.02.013 · Cited by 31
Ohkawara, H., Ishibashi, T., Saitoh, S.-I., Inoue, N., Sugimoto, K., Kamioka, M., Uekita, H., Kaneshiro, T., Ando, K., Takuwa, Y., et al. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq221 · Cited by 27
Koskinas, K. C., Windecker, S., Buhayer, A., Gencer, B., Pedrazzini, G., Mueller, C., Cook, S., Muller, O., Matter, C. M., Räber, L., et al. (2018) · Clinical Cardiology · doi:10.1002/clc.23112 · Cited by 26
Shamloo, A., & Forouzandehmehr, M. (2019) · Biomechanics and Modeling in Mechanobiology · doi:10.1007/s10237-018-01116-y · Cited by 25
Treg/Th17 Ratio Acts as a Novel Indicator for Acute Coronary Syndrome
Li, Q., Wang, Y., Wang, Y., Chen, K., Zhou, Q., Wei, W., & Wang, Y. (2014) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-014-9993-5 · Cited by 24
Zhang, F., Sun, D., Chen, J., et al. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2871 · Cited by 24
Kawashiri, M., Nohara, A., Higashikata, T., Tada, H., Nakanishi, C., Okada, H., Konno, T., Sakata, K., Hayashi, K., Inazu, A., et al. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.09.011 · Cited by 24
Structure, Signalling and Physiologic Role of Adiponectin-Dietary and Exercise- Related Variations
Hickman, I. J., & Whitehead, J. P. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712803833155 · Cited by 22
Hansen, M., Kuhlman, A. B., Sahl, R. E., Kelly, B., Morville, T. H., Dohlmann, T. L., Chrøis, K. M., Larsen, S., Helge, J. W., & Dela, F. (2018) · Cytokine · doi:10.1016/j.cyto.2018.10.011 · Cited by 18
Ueland, T., Kleveland, O., Michelsen, A. E., Wiseth, R., Damås, J. K., Aukrust, P., Gullestad, L. L., Halvorsen, B. L., & Yndestad, A. (2018) · Open Heart · doi:10.1136/openhrt-2017-000765 · Cited by 16
Howarth, A. G., Wiehler, W. B., Pannirselvam, M., Jiang, Y., Berger, J. P., Severson, D. L., Anderson, T. J., & Triggle, C. R. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.086397 · Cited by 13
Lekić, A., Brekalo, Z., Kvesić, A., Kovačević, M., Baricev‐Novakovic, Z., Sutic, I., Bulog, A., Sutic, I., Pavišić, V., & Mrakovčić-Šutić, I. (2017) · Scandinavian Journal of Immunology · doi:10.1111/sji.12563 · Cited by 13
Stem Cell-Based Therapies for Atherosclerosis: Perspectives and Ongoing Controversies
Zhang, N., Xie, X., Chen, H., Chen, H., Yu, H., & Wang, J.-A. (2014) · Stem Cells and Development · doi:10.1089/scd.2014.0078 · Cited by 9
Aspirin for the Primary Prevention of Cardiovascular Disease: Weighing Up the Evidence
Murphy, S., McCarthy, C. P., & McEvoy, J. W. (2019) · The American Journal of Medicine · doi:10.1016/j.amjmed.2019.02.025 · Cited by 7
Oral antiplatelets in primary and secondary prevention of myocardial infarction: a review
Doshi, R. P., Vadher, A., Mithawala, P., & Shah, P. (2018) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-018-1897-8 · Cited by 5
Cited by
Medina-Leyte, D. J., Zepeda-García, O., Domínguez-Pérez, M., González-Garrido, A., Villarreal-Molina, T., & Jacobo-Albavera, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083850 · Cited by 623
Metabolic syndrome and cardiovascular diseases: Going beyond traditional risk factors
Silveira Rossi, J. L., Barbalho, S. M., Reverete de Araujo, R., Bechara, M. D., Sloan, K. P., & Sloan, L. A. (2022) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3502 · Cited by 604
Multifunctional nanoparticle-mediated combining therapy for human diseases
Li, X., Peng, X., Zoulikha, M., Boafo, G. F., Magar, K. T., Ju, Y., & He, W. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01668-1 · Cited by 521
Afzal, S., Abdul Manap, A. S., Attiq, A., Albokhadaim, I., Kandeel, M., & Alhojaily, S. M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1269581 · Cited by 416
Oxidative Stress: Signaling Pathways, Biological Functions, and Disease
Liu, S., Liu, J., Wang, Y., Deng, F., & Deng, Z. (2025) · MedComm · doi:10.1002/mco2.70268 · Cited by 359
Metadata
- Authors
- Marchio, P., Guerra-Ojeda, S., Vila, J. M., Aldasoro, M., Victor, V. M., & Mauricio, M. D.
- Venue
- Oxidative Medicine and Cellular Longevity
- Publisher
- Wiley
- Published
- 2019-07-01
- Volume
- 2019
- Pages
- 1-32
- ISSN
- 1942-0994 (ISSN-L)
- 1942-0900
- OpenAlex
- W2953536521
- Cited by
- 621
- References
- 312
- FWCI
- 22.75
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.